Clinical Trial Update: Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pneumococcal vaccination in multiple myeloma patients receiving novel therapies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Pneumococcal Infection

Snippet

Sponsor: Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | Conditions: Multiple Myeloma, Pneumococcal Infection | Phase 4 | Status: COMPLETED